Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
Conditions
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
- Primary Mediastinal Large B-Cell Lymphoma
- Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
- PROCEDURE: Biopsy
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Computed Tomography
- BIOLOGICAL: Epcoritamab
- PROCEDURE: Magnetic Resonance Imaging
- OTHER: Patient Observation
- PROCEDURE: Positron Emission Tomography
Sponsor
Academic and Community Cancer Research United
Collaborators